CAMZAVA
Dead / Abandoned — Abandoned — no statement of use filed (as of 04 Sept 2023)
What this means for you
This application is over — abandoned 04 Sept 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90002817
- Mark type
- Stylized text
- Filed
- 16 Jun 2020
- Published for opposition
- 08 Dec 2020
- Abandoned
- 04 Sept 2023
- Attorney of record
- Mark A. Paskar
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of chronic pancreatitis; oral serine protease inhibitor for the treatment of chronic pancreatitis
Owner
- Sagent Pharmaceuticals, Inc., Schaumburg, IL, US
- Sagent Pharmaceuticals, Inc., Schaumburg, IL, US
Prosecution history
- 05 Sept 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 04 Sept 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 30 Mar 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Mar 2023 — SOU EXTENSION 4 GRANTED
- 02 Feb 2023 — SOU EXTENSION 4 FILED
- 27 Mar 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 06 Feb 2023 — NOTICE OF REVIVAL - E-MAILED
- 06 Feb 2023 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 06 Feb 2023 — PETITION TO REVIVE-GRANTED
- 06 Feb 2023 — TEAS PETITION TO REVIVE RECEIVED
- 03 Aug 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Aug 2022 — SOU EXTENSION 3 GRANTED
- 01 Aug 2022 — SOU EXTENSION 3 FILED
- 01 Aug 2022 — SOU TEAS EXTENSION RECEIVED
- 24 Dec 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED